DogYears
We are developing a new gene therapy to help our canine companions stay stronger, move more comfortably, and enjoy healthier lives as they age. By supporting muscle growth, easing pain, and calming inflammation linked to arthritis, our follistatin therapy aims to improve everyday mobility and overall wellbeing.
Community Sentiment
How do you feel about this ipt?
Project
Market Overview
Summary
Dog Years DAO is creating a breakthrough therapy to help dogs and people live longer, healthier lives by reducing muscle loss, pain, and inflammation caused by aging and arthritis.
Problem
This project tackles muscle loss from aging and pain caused by arthritis in dogs, aiming to improve their mobility, comfort, and quality of life as they grow older.
Impact
Unlocking healthier, longer lives for dogs and humans, this project pioneers DeSci drug development—combining biotech, crypto, and on-chain data to advance therapies that fight aging, pain, and inflammation.
Market Overview
Summary
Dog Years DAO is creating a breakthrough therapy to help dogs and people live longer, healthier lives by reducing muscle loss, pain, and inflammation caused by aging and arthritis.
Problem
This project tackles muscle loss from aging and pain caused by arthritis in dogs, aiming to improve their mobility, comfort, and quality of life as they grow older.
Impact
Unlocking healthier, longer lives for dogs and humans, this project pioneers DeSci drug development—combining biotech, crypto, and on-chain data to advance therapies that fight aging, pain, and inflammation.
The project leverages proprietary data to develop and secure patents, creating valuable intellectual property assets. These patents, along with the underlying data, are then licensed to third parties, generating revenue streams from organizations seeking access to innovative technologies and datasets.
A portion of the proceeds from licensing activities is used to buy back and burn project tokens, reducing token supply and potentially increasing their value. This model aligns the interests of token holders with the project’s commercial success, creating a sustainable cycle of value creation and distribution.
$DYFST Token Launch with Bio protocol
Pilot Study (US) Recruitment Begins
Pilot Study for Follistatin Begins
Data Licensed to Strategic Partners
Decentralized, Longitudinal Study Begins
Follistatin Gene Delivery Enhances Muscle Growth and Strength in Nonhuman Primates
https://www.science.org/doi/abs/10.1126/scitranslmed.3000112
Gene therapy for follistatin mitigates systemic metabolic inflammation and post-traumatic arthritis in high-fat diet–induced obesity
https://www.science.org/doi/full/10.1126/sciadv.aaz7492
This biohacking company is using a crypto city to test controversial gene therapies
https://www.technologyreview.com/2023/02/13/1068330/minicircle-prospera-honduras-biohacking-follistatin-gene-therapy/
Healthy ageing and the science of longevity in dogs
https://www.magonlinelibrary.com/doi/abs/10.12968/coan.2018.23.9.514
Follistatin Alleviates Synovitis and Articular Cartilage Degeneration Induced by Carrageenan
https://onlinelibrary.wiley.com/doi/10.1155/2014/959271
Community
Stay up to date
Get the latest community updates and find out about upcoming DogYears developments
